Vascular risk, gait, behavioral, and plasma indicators of VCID
Sheelakumari Raghavan(Mayo Clinic), Prashanthi Vemuri(Mayo Clinic in Arizona), Maria Vassilaki(Mayo Clinic), Robert I. Reid(Mayo Clinic), B. Gwen Windham(Jackson Memorial Hospital), Scott A. Przybelski(Mayo Clinic in Florida), Mary M. Machulda(Mayo Clinic), Alicia Algeciras‐Schimnich(Mayo Clinic), Ronald C. Petersen(Mayo Clinic in Arizona), Robel K Gebre(Mayo Clinic), Timothy G. Lesnick(Mayo Clinic in Florida), David S. Knopman(Mayo Clinic), Clifford R. Jack(Mayo Clinic), Angela J. Fought(Mayo Clinic in Florida), Jonathan Graff‐Radford(Mayo Clinic)
Cited by 16
Related Papers
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|18.9k
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Mild cognitive impairment as a diagnostic entity
|Journal of Internal Medicine|2004|7.8k
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|7.1k
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
|Journal of Internal Medicine|2004|5k